Shandong Sinobioway Biomedicine Co., Ltd. (SHE:002581)
China flag China · Delayed Price · Currency is CNY
4.540
-0.240 (-5.02%)
May 21, 2026, 3:04 PM CST

SHE:002581 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
153.86220.25506.4151.91183.8187.8
Trading Asset Securities
0.020.02----
Cash & Short-Term Investments
153.88220.27506.4151.91183.8187.8
Cash Growth
-65.42%-56.50%233.35%-17.35%-2.13%-33.91%
Accounts Receivable
253.81279.6693.32172.62179.72272.96
Other Receivables
9.1212.0552.2478.8718.3613.49
Receivables
262.93291.72145.55251.49198.09286.45
Inventory
116.8293.2579.6485.3180.0464.33
Other Current Assets
22.3724.115.417.9956.4329.88
Total Current Assets
556629.34747.01496.71518.36568.45
Property, Plant & Equipment
351.08350.09274.74357.84705.47713.76
Long-Term Investments
922.78938.341,0561,3551,5031,223
Other Intangible Assets
89.0490.8193.47108.29126.32134.29
Long-Term Deferred Tax Assets
27.6927.3211.216.1211.8425.28
Long-Term Deferred Charges
15.639.730.321.415.27.78
Other Long-Term Assets
127.63122.7413.4412.260.4983.36
Total Assets
2,0902,1682,1962,3372,8702,756
Accounts Payable
77.8388.3935.3573.6943.6442.13
Accrued Expenses
7.4213.3420.8322.519.3231.01
Short-Term Debt
27.532.532.7713.84150.42151.54
Current Portion of Long-Term Debt
16.5817.72----
Current Portion of Leases
--0.17-13.4615.83
Current Income Taxes Payable
1.324.22-0.951.20.44
Current Unearned Revenue
2.472.9210.463.5926.863.43
Other Current Liabilities
19.0331.6613.0319.03109.3814.17
Total Current Liabilities
152.17190.7882.61133.61364.28258.54
Long-Term Debt
108.5----
Long-Term Leases
3.522.69-0.711.479.8
Long-Term Unearned Revenue
5.495.495.495.496.719.74
Long-Term Deferred Tax Liabilities
9.669.599.397.517.688.68
Other Long-Term Liabilities
4.934.9476.1216.099.67-
Total Liabilities
185.78222173.61163.41389.82286.76
Common Stock
229.15229.15229.15229.15229.15229.15
Additional Paid-In Capital
917.16901.28866.41873.93858.5858.29
Retained Earnings
657.57711.79828.08965.391,2981,301
Total Common Equity
1,8041,8421,9242,0682,3852,388
Minority Interest
100.2104.1698.67105.2694.9481.11
Shareholders' Equity
1,9041,9462,0222,1742,4802,469
Total Liabilities & Equity
2,0902,1682,1962,3372,8702,756
Total Debt
57.6161.432.9414.55165.35177.16
Net Cash (Debt)
96.27158.84503.47137.3618.4510.64
Net Cash Growth
-78.05%-68.45%266.52%644.38%73.50%-90.91%
Net Cash Per Share
0.150.240.760.210.030.02
Filing Date Shares Outstanding
659.68659.1659.74659.74659.74659.74
Total Common Shares Outstanding
659.68659.1659.74659.74659.74659.74
Working Capital
403.83438.56664.4363.1154.08309.91
Book Value Per Share
2.732.802.923.143.623.62
Tangible Book Value
1,7151,7511,8301,9602,2592,254
Tangible Book Value Per Share
2.602.662.772.973.423.42
Buildings
--393.55486.08639.62612.92
Machinery
--431.4432.25413.16424.47
Construction In Progress
--38.1122.1791.4364.86
Source: S&P Global Market Intelligence. Standard template. Financial Sources.